## SNPS: Synopsys, Inc. - XLK: Technology

### Executive Summary

No thesis match: MRS_10 0.1% below STRENGTH zone (3.0-6.0%); PEG 6.26 fails VALUE criteria (<1.0). Stock is in no-man's land without clear edge.

- **Horizon:** N/A - no position
- **Risk Profile:** N/A - avoiding
- **Stop Type:** Fixed 2xATR ($426.45)
- **If Wrong:** N/A - wait for clearer setup
- **Invalidation:** MRS_10 falling below -5% or breaking key support

### News

- **Articles:** 10
- **Sentiment:** Bearish (Bullish: 0, Bearish: 8)

**1. SNPS Investors Have Opportunity to Lead Synopsys, Inc. Securities Fraud Lawsuit**
- Source: Morningstar | 20251217T231002 | Bearish | Relevance: 100%
- The Rosen Law Firm reminds purchasers of Synopsys, Inc. (NASDAQ: SNPS) securities between December 4, 2024, and September 9, 2025, of the upcoming December 30, 2025, lead plaintiff deadline for a securities fraud lawsuit. The lawsuit alleges that Synopsys made materially false and/or misleading statements regarding how its focus on AI customers negatively impacted its Design IP business's economics and financial results. Investors who purchased SNPS securities during the Class Period may be entitled to compensation and are encouraged to contact Rosen Law Firm to join the class action.

**2. Synopsys, Inc. Notice of Application Deadline for Recovery**
- Source: GlobeNewswire | 20251217T040934 | Bearish | Relevance: 100%
- Kahn Swick & Foti, LLC (KSF) has notified investors in Synopsys, Inc. (NasdaqGS: SNPS) of a class action securities lawsuit. The lawsuit seeks to recover losses for investors affected by alleged securities fraud between December 4, 2024, and September 9, 2025, or those who acquired Synopsys common stock through the Ansys acquisition. Investors who suffered losses have until December 30, 2025, to request appointment as lead plaintiff.

**3. Join Class Action to Recover Losses From Synopsys, Inc. (SNPS) - Contact Levi & Korsinsky Before December 30, 2025**
- Source: WWLP | 20251217T030952 | Bearish | Relevance: 100%
- Levi & Korsinsky, LLP has filed a class action securities lawsuit against Synopsys, Inc. for investors who suffered losses due to alleged securities fraud between December 4, 2024, and September 9, 2025. The lawsuit claims Synopsys made false statements about the deteriorating economics of its Design IP business due to increased focus on AI customers and the negative impact on financial results. Investors are encouraged to contact the firm before December 30, 2025, to explore potential recovery.

**4. Levi & Korsinsky Urges Synopsys, Inc. (SNPS) Shareholders to Act Before Lead Plaintiff Deadline December 30, 2025**
- Source: WANE 15 | 20251216T210824 | Bearish | Relevance: 100%
- Levi & Korsinsky, LLP has announced that a securities class action lawsuit has been filed against Synopsys, Inc. (NASDAQ: SNPS) on behalf of investors who purchased securities between December 4, 2024, and September 9, 2025. The lawsuit alleges that Synopsys made false statements regarding its Design IP business and the impact of increased focus on AI customers. Shareholders who suffered losses are urged to contact Levi & Korsinsky before the lead plaintiff deadline of December 30, 2025, to explore their rights.

**5. Synopsys (SNPS) Stock News Today (Dec. 16, 2025): Fresh Analyst Forecasts, JPMorgan “Top Picks” Call, and What Q4 Results Signal for 2026**
- Source: ts2.tech | 20251216T200843 | Somewhat-Bullish | Relevance: 100%
- Synopsys (SNPS) stock is experiencing renewed investor focus due to new Wall Street price-target updates, a "top picks" designation from JPMorgan, and legal notices regarding a class action lawsuit. Investors are balancing the post-earnings reset, including the Ansys acquisition and IP business performance, against strategic tailwinds like AI infrastructure demand and a deepened partnership with Nvidia. Analyst forecasts are generally constructive, with consensus price targets clustering in the mid-$500s, reflecting both optimism about Synopsys' strategic positioning and caution regarding IP growth, geopolitical risks, and integration execution.

### Analyst Activity

**Target Signal:** NEUTRAL (Raises: 6, Lowers: 5)

| Date | Firm | Target | Prior | Change |
|------|------|--------|-------|--------|
| 2025-12-12 | Morgan Stanley | $550 | $510 | +8% |
| 2025-12-11 | JP Morgan | $650 | $600 | +8% |
| 2025-12-11 | Wells Fargo | $500 | $445 | +12% |
| 2025-12-11 | Keybanc | $600 | $575 | +4% |

**Rating Changes:**

| Date | Firm | Action | Grade |
|------|------|--------|-------|
| 2025-12-12 | Morgan Stanley | main | Overweight |
| 2025-12-11 | JP Morgan | main | Overweight |
| 2025-12-11 | Wells Fargo | main | Equal-Weight |
| 2025-12-11 | Keybanc | main | Overweight |

### Insider Activity (90 days)

| Metric | Value |
|--------|-------|
| Direction | **MIXED** |
| Buys | 3 ($0.00M) |
| Sells | 4 ($0.00M) |

### Institutional Ownership

| Metric | Value |
|--------|-------|
| Total Ownership | 40.5% |
| Smart Money | **BULLISH** |
| Net Flow | 0.0% |
| Buying/Selling | 8 / 2 |

**Top Holders:**
- Vanguard Group Inc: 9.8% (+20.7%)
- Blackrock Inc.: 8.2% (+18.5%)
- State Street Corpora: 4.7% (+20.6%)
- Capital World Invest: 4.0% (-3.7%)
- FMR, LLC: 3.1% (+47.5%)

### Key Risks

1. Valuation stretched: PEG 6.3x requires aggressive growth execution.
2. Long-term trend broken: trading 6.2% below SMA200.
3. Market regime shift could impact momentum names disproportionately.

### Catalysts

- Analyst target momentum: 6 raises (avg +8%) could attract flows.
- AI/machine learning initiatives could drive multiple expansion if executed.

### Fundamentals

PEG ratio 6.26 signals overvaluation risk, limited margin of safety. Quality metrics strong (margin 19%). Analyst sentiment positive (6 raises, avg +8%). Institutional flow bullish (8 buying vs 2 selling).

| Metric | Value |
|--------|-------|
| Market Cap | $87.3B |
| Beta | 1.15 |
| 52W Range | $365.74 - $651.73 |
| Short Interest | 2.5% |

| Valuation | Value |
|-----------|-------|
| PEG Ratio | 6.26 |
| Forward P/E | 27.1 |
| Current P/E | 31.8 |
| YoY Growth | 17.7% |
| EPS Direction | STABLE |

### Technicals

MRS_10 improving modestly (+0.9% over 5 days). Below STRENGTH zone by 2.9pp (needs >3.0% for momentum thesis). MRS_5 at 0.4% confirms short-term momentum alignment. Below SMA200 (0.94x), long-term trend not supportive. MACD histogram positive (1.15), confirming momentum. RSI neutral at 56. OFD pattern: -SUL (Resistance).

| Metric | Value | Signal |
|--------|-------|--------|
| MRS_10 | 0.14% (CS: 38) | Neutral |
| RSI_14 | 56.5 | Neutral |
| MACD Histogram | 1.15 | Bullish |
| vs SMA20 | 1.034x | Above |
| vs SMA50 | 1.053x | Above |
| vs SMA200 | 0.938x | Below |

### Decision

- **Verdict:** AVOID
- **Thesis:** NEUTRAL

### Trade Setup

- **Entry:** $458.13
- **Stop Loss:** $426.45 (6.9% risk)
- **Target:** $489.81 (R:R method)
- **Risk/Reward:** 1.00:1
- **Target Reasoning:** NEUTRAL thesis targets 1.0x risk/reward based on historical edge

### Position Sizing

- **Shares:** 29
- **Position Value:** $13,285.77
- **Portfolio %:** 13.29%
- **Risk Dollars:** $950.00
- **Risk Per Trade:** 0.95%
- **Modifiers:** L1 95% | L2 100% | Combined 0.95x

### Market Context

| Layer | Signal | Modifier |
|-------|--------|----------|
| L1 Macro | NORMAL (MEDIUM) | 0.95x |
| L2 Sector | NEUTRAL (Zone E) | 1.00x |

*NORMAL regime with cautious positioning ahead of CPI data. VIX at moderate 16.87 with positive yield curve suggesting stable growth, but narrow breadth at 51.8% indicates selective participation. Banking sector optimism and corporate resilience provide support, though AI volatility creates pockets of uncertainty.*

### Earnings

| Quarter | Est | Actual | Surprise |
|---------|-----|--------|----------|
| 2025Q4 | $2.88 | $2.90 | +0.7% |
| 2025Q3 | $3.75 | $3.39 | -9.5% |
| 2025Q2 | $3.40 | $3.67 | +8.0% |
| 2025Q1 | $2.79 | $3.03 | +8.6% |

---
*RULE-based L3 | 2026-01-06 16:38 | MRS_10*